RecruitingPhase 3NCT02568878

Creatine for Depressed Male and Female Methamphetamine Users

An Open-Label Pilot Study of Creatine for Depressed Male and Female Methamphetamine Users


Sponsor

Montana State University

Enrollment

29 participants

Start Date

Nov 1, 2015

Study Type

INTERVENTIONAL

Conditions

Summary

* Assess the antidepressant/anxiolytic effect of creatine in male and female methamphetamine users * Assess creatine's effect on methamphetamine use * Assess the safety of creatine in male methamphetamine users with depression


Eligibility

Min Age: 18 YearsMax Age: 59 Years

Plain Language Summary

Simplified for easier understanding

This trial is testing whether the nutritional supplement creatine can help reduce depression and anxiety symptoms in people who use methamphetamine (crystal meth) and have been diagnosed with depression and anxiety. **You may be eligible if...** - You currently use methamphetamine as your primary substance of use - You have been diagnosed with major depressive disorder (whether caused by methamphetamine or independent of it) - You also have a diagnosis of an anxiety disorder - Your depression score (Hamilton Depression Rating Scale) is 16 or higher - Your anxiety score (Hamilton Anxiety Scale) is 18 or higher - If you are on a psychiatric medication, your dose has been stable for at least 4 weeks **You may NOT be eligible if...** - You are unable to give informed consent - You are at significant risk of suicide or harming others - Your primary substance use disorder is something other than methamphetamine - You are pregnant (if female) - You have a history of kidney disease - You have a significant medical or neurological illness - You have had a previous allergic reaction to creatine Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGCreatine monohydrate

Locations(1)

Montana State University College of Nursing (Missoula campus)

Missoula, Montana, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT02568878


Related Trials